NO ATC N01BB02 · updated 2 Nov 2026
Lidocaine shortage in Norway
Is there a Lidocaine shortage in Norway?
Yes. As of 2 Nov 2026, 4 Lidocaine products are reported short in Norway, the first since 1 Oct 2025. The company estimate for the return is 31 Jan 2027 (latest 1 Sep 2030). Main reason: commercial decision or withdrawal.
Also short in United States, Canada, Italy, Spain, Austria, Switzerland, Sweden, Australia. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Lidokain Aguettant 10 mg/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 10x10 ml ferdigfylt sprøyte | Laboratoire Aguettant | 1 Oct 2025 | 1 Oct 2027 | Commercial decision or withdrawal Kommersielle grunner |
| NO | Lidokain Aguettant 20 mg/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 10x10 ml ferdigfylt sprøyte | Laboratoire Aguettant | 1 Oct 2025 | 1 Oct 2027 | Commercial decision or withdrawal Kommersielle grunner |
| NO | Lidocaine Accord 20 mg/ml injeksjonsvæske, oppløsning, 20 ml hetteglass | Accord Healthcare B.V. | 28 Dec 2025 | 1 Sep 2030 | Increased demand Uventet økt etterspørsel |
| NO | Lidocaine Accord 10 mg/ml injeksjonsvæske, oppløsning, 20 ml hetteglass | Accord Healthcare B.V. | 1 Oct 2026 | 31 Jan 2027 | Commercial decision or withdrawal Kommersielle grunner |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).